APT Medical Inc (688617) — Cash Flow Reinvestment Rate
APT Medical Inc (688617) has a Cash Flow Reinvestment Rate of 0.67x as of December 2025, reinvesting CN¥196.93 Million (capex CN¥52.10 Million plus investments CN¥144.83 Million) from operating cash flow of CN¥294.68 Million. Check 688617 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
APT Medical Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for APT Medical Inc across 9 annual periods. Explore APT Medical Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for APT Medical Inc (2017–2025)
Year-by-year capital reinvestment analysis for APT Medical Inc. For live market cap and broader valuation context, see how much is APT Medical Inc worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CN¥501.12 Million | CN¥975.30 Million | CN¥285.59 Million | ▼ -43.9% |
| 2024 | 0.92x | CN¥681.04 Million | CN¥743.39 Million | CN¥650.24 Million | ▼ -19.5% |
| 2023 | 1.14x | CN¥783.93 Million | CN¥689.06 Million | CN¥202.03 Million | ▲ +50.5% |
| 2022 | 0.76x | CN¥277.73 Million | CN¥367.46 Million | CN¥143.21 Million | ▼ -89.3% |
| 2021 | 7.04x | CN¥1.28 Billion | CN¥181.39 Million | CN¥167.38 Million | ▲ +2223.6% |
| 2020 | 0.30x | CN¥44.93 Million | CN¥148.24 Million | CN¥44.20 Million | ▼ -87.7% |
| 2019 | 2.47x | CN¥135.59 Million | CN¥54.90 Million | CN¥67.56 Million | ▲ +42.9% |
| 2018 | 1.73x | CN¥32.20 Million | CN¥18.63 Million | CN¥32.20 Million | ▼ -11.7% |
| 2017 | 1.96x | CN¥25.26 Million | CN¥12.91 Million | CN¥25.26 Million | — |